2-iodomelatonin has been researched along with cyclic gmp in 1 studies
Studies (2-iodomelatonin) | Trials (2-iodomelatonin) | Recent Studies (post-2010) (2-iodomelatonin) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
---|---|---|---|---|---|
245 | 0 | 10 | 22,346 | 333 | 4,062 |
Protein | Taxonomy | 2-iodomelatonin (IC50) | cyclic gmp (IC50) |
---|---|---|---|
Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calvo, JR; Guerrero, JM; Lopez-Gonzalez, MA; Osuna, C | 1 |
1 other study(ies) available for 2-iodomelatonin and cyclic gmp
Article | Year |
---|---|
Interaction of melatonin with human lymphocytes: evidence for binding sites coupled to potentiation of cyclic AMP stimulated by vasoactive intestinal peptide and activation of cyclic GMP.
Topics: Binding, Competitive; Cell Membrane; Cyclic AMP; Cyclic GMP; Drug Synergism; Humans; Lymphocytes; Melatonin; Purine Nucleotides; Pyrimidine Nucleotides; Receptors, Melatonin; Receptors, Neurotransmitter; Vasoactive Intestinal Peptide | 1992 |